Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: SEPTEMBER ISSUE PUBLISHED
  • SEPTEMBER 2021 Issue has been successfully launched on 1 September 2021.

Abstract

FORMULATION AND EVALUATION OF GLIBENCLAMIDE LOADED PRONIOSOMAL GEL FOR TRANSDERMAL DRUG DELIVERY

Ranjeetha A. R.*, Vazir Ashfaq Ahmed, Priyanka Raj G., Swathi K., Rashmitha N. M., Monisha M. N., Vanendra Yadav

ABSTRACT

The aim of the present investigation, an attempt was made to formulate Glibenclamide loaded proniosomal gel in order to increase bioavailability and reduce side effects by achieving transdermal drug delivery. Proniosomal gel were prepared by co-accervation technique by varying the excipients .such as cholesterol, soyalecithin, span 60, span 40, tween 20. The prepared gel is characterized by particle size and zeta potential analysis, vesicle size distribution, surface morphology, determination of % drug content and % drug entrapment efficiency, in- vitro drug release. Drug and physical mixture were characterized by FTIR, which confirms that no interaction occur between drug and excipient. Zeta potential of optimized formulations were measured by zeta analyzer and found that-8.2mV(SF4), 6.3mV(S1F3), -5.7mV(TF3) and 3.1mV(T1F3) for the respective formulation, Which indicates they are sufficiently stable. The particle size also determined by Zeta particle analyzer for optimized formulation SF4 - 53.0nm, S1F3 - 51.5nm, TF3 - 52.4nm and T1F3 - 59.7nm.

Keywords: Glibenclamide, Proniosomes, co-accervation method, in vitro.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More